Do most young people who take puberty blockers go on to take gender-affirming hormones?

Research shows that the vast majority of young people who take puberty blockers do continue on to gender-affirming hormones. This statistic is often cited in newspapers, sometimes with concern about whether blockers truly provide a 'pause' for reflection.

Evidence indicates that this pattern reflects the careful assessment process that happens before blockers are prescribed. Young people who reach the point of needing puberty blockers have typically already experienced significant distress about their developing body and have undergone thorough evaluation by healthcare professionals. The high continuation rate suggests that blockers are being prescribed appropriately to those who genuinely need them, rather than indicating that blockers somehow 'cause' people to be transgender.

Guidelines recommend that puberty blockers are used as part of a comprehensive treatment approach, following detailed psychological and medical assessment. The decision to prescribe blockers represents a significant milestone in a young person's healthcare journey, reached only after careful consideration of their individual circumstances and persistent gender dysphoria.

Understanding this context helps explain why continuation rates are high and provides reassurance that these medications are being used thoughtfully as part of evidence-based care for young people experiencing gender dysphoria.